CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
about
A novel computational biostatistics approach implies impaired dephosphorylation of growth factor receptors as associated with severity of autism.Pancreatic cancer stem cell markers and exosomes - the incentive pushInteraction of the Oncofetal Thomsen-Friedenreich Antigen with Galectins in Cancer Progression and MetastasisCellular Barriers after Extravasation: Leukocyte Interactions with Polarized Epithelia in the Inflamed TissueAberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerEndometrial stem/progenitor cells: the first 10 yearsRoles of Proteoglycans and Glycosaminoglycans in Wound Healing and FibrosisUtilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy DeliveryKey Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem CellsPrognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysisSAM68: Signal Transduction and RNA Metabolism in Human CancerIncreased Oxidative Stress as a Selective Anticancer TherapyThe 'alternative' EMT switchCD44 Acts as a Signaling Platform Controlling Tumor Progression and MetastasisAntioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem CellsCD44 as a potential diagnostic tumor markerEpithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compoundsInteractions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and CancerSignificance of CD44 expression in head and neck cancer: a systemic review and meta-analysisEffect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemiaIduronic acid in chondroitin/dermatan sulfate affects directional migration of aortic smooth muscle cellsTargeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft ModelStructural basis of DDB1-and-Cullin 4-associated Factor 1 (DCAF1) recognition by merlin/NF2 and its implication in tumorigenesis by CD44-mediated inhibition of merlin suppression of DCAF1 functionCirculating and disseminated tumor cells: diagnostic tools and therapeutic targets in motionAdipose extracellular matrix remodelling in obesity and insulin resistanceConcise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic TargetMechanisms involved in breast cancer liver metastasisCD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating CellsPhosphatidylinositol 4,5-bisphosphate clusters the cell adhesion molecule CD44 and assembles a specific CD44-Ezrin heterocomplex, as revealed by small angle neutron scatteringThe invasion and metastasis promotion role of CD97 small isoform in gastric carcinoman-Butyl benzyl phthalate promotes breast cancer progression by inducing expression of lymphoid enhancer factor 1Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cellsOvarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypesTargeting Serglycin Prevents Metastasis in Murine Mammary CarcinomaDynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow.Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METLysosomal degradation of CD44 mediates ceramide nanoliposome-induced anoikis and diminished extravasation in metastatic carcinoma cells.Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment.Melanoma upregulates ICAM-1 expression on endothelial cells through engagement of tumor CD44 with endothelial E-selectin and activation of a PKCα-p38-SP-1 pathway.
P2860
Q24612710-31961129-DAD8-41A9-A4DB-E13F7DF26E25Q26741215-1C7DBE5C-05EA-4B44-9673-86A9EC397024Q26749378-57D2539E-8D16-4509-B439-38BCFC38FA16Q26768643-900FDBF9-019C-48CC-8603-E5DCA1CB0D4BQ26773907-4072B91B-6BF9-4B58-A2FD-6BD69DAABC07Q26778310-D883527F-7578-4C78-8452-BC70E4CDFAE2Q26786042-577AC441-C7B9-41ED-93B7-E688162E9816Q26786070-0ECA4F96-B61E-4792-A83B-17BDE434521EQ26795737-F44D569F-BC07-47FD-A321-F9931FAE3182Q26796554-07C7499F-AB64-4064-986E-50F5A9115475Q26798149-35FB1413-E26F-4595-A1E3-1129E179945AQ26798210-395634DB-DA0A-4948-A08D-2E47F71921F9Q26823268-FF5E8E18-859F-4949-B135-A9DCA8F2C823Q26851466-F5C916EF-F286-4026-AB1E-BBC7273492E5Q26853528-E8F48E06-05E6-495A-8DE1-4C966011E754Q26866085-2CBA8FFA-99A8-4306-AC21-062F697915C0Q27013565-85D86D69-4288-4614-9343-1286B9BDA235Q27021261-86D33893-4AF1-49E6-A335-D9BDDC6AA1F7Q27023399-8360BDC1-14F6-47E6-8ADF-0CC993233086Q27309004-99952EE6-6A52-47C8-B39A-C3D8F72C57F3Q27313839-5F18DC85-7AD6-430A-947C-997319E33358Q27333471-923D7AC6-7C62-42C5-AEAB-FBFC7C80E5B3Q27690668-98393F83-C0B9-4099-8F1E-296EDB486B17Q28066285-1C5F9733-43D0-4638-AA6B-2110990D4116Q28069494-0E07510D-D2AA-48EF-82DF-151FE85923EEQ28083115-7D37F1DA-F450-4752-8265-22F51F06F2DDQ28084024-45E22E3F-8A25-4CA3-BBB2-8AEA3A5ECDC4Q28084610-93940771-2F28-4757-BF75-BFDFDA1030F2Q28255119-514442C8-F8B1-44A0-9671-5F124C030C05Q28270529-C1433849-CD83-41C5-9D06-9E2CBC82BCA5Q28482126-9222455F-C6E3-4E55-9246-827BBEAAF3D1Q28539620-D7A4ED07-CD30-430B-BC88-50C1B718552FQ28543021-8F9BE275-2F96-42AE-AD7E-A814C5C87211Q28552442-D0B56618-291F-41C4-8526-677F52929FF2Q28818141-A0C02200-5402-465F-B202-45C03AA65CBCQ29618139-3AF08B31-8346-4C9A-92D6-19DA0C17969AQ30300775-6A9C8D91-D1BA-4B53-BEA8-FA9F8EE32317Q30357883-91292EBD-355B-4D15-95D3-C77936B3CF1EQ30378139-5CE70F9C-83D2-426B-90F9-51641DA606E6Q30399793-E26549BE-8ABF-4D47-82AC-E8AAD06D1500
P2860
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
@en
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
@nl
type
label
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
@en
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
@nl
prefLabel
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
@en
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
@nl
P356
P1476
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
@en
P2093
Margot Zöller
P2888
P304
P356
10.1038/NRC3023
P407
P577
2011-03-10T00:00:00Z